(lp0
S"Galectin Therapeutics Reports 2016 Financial Results and Provides Business Update GlobeNewswire  - 18 hours ago NORCROSS, Ga., March 28, 2017  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, today reported financial results for the year ended December 31, 2016.Galectin Therapeutics'  CEO, Peter Traber on Q4 2016 Results - Earnings ... - Seeking Alpha"
p1
aS'Galectin Therapeutics to Present at BIO CEO &amp; Investor Conference GlobeNewswire  - Feb 8, 2017 NORCROSS, Ga., Feb. 08, 2017  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, today announced that Harold Shlevin, Ph.Small Cap Galectin Therapeutics is Sending Bullish Messages - SmallCap Networkanalysts Recommendations: Galectin Therapeutics, Inc.  - News Oracle'
p2
aS'Galectin Therapeutics Inc  Is An Alternative Catalyst Play Insider Financial - Feb 16, 2017 Galectin Therapeutics Inc  is drawing some considerable volume at the moment, and the company is up more than 45% this week alone as a result.'
p3
aS'Galectin Therapeutics Issues Statement Regarding GALTW and GALTU Nasdaq - Mar 23, 2017 NORCROSS, Ga., March 23, 2017  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, announced today that trading will be halted in GALTW and GALTU at close of business&nbsp;...Trading in certain Galectin warrants ends today; trading in stock unaffected - Seeking Alpha'
p4
aS"Why Galectin Therapeutics Just Lost Nearly Half Its Market Cap Benzinga - Sep 28, 2016 Shares of Galectin Therapeutics Inc , a clinical-stage biopharmaceutical company that creates therapies for fibrotic disease and cancer, tumbled nearly 50 percent on Wednesday after the company said that a Phase 2a study called NASH-FX&nbsp;...Galectin Therapeutics Announces Top-Line Data from Exploratory Phase 2a Pilot ... - GlobeNewswire Stock Update : Here's Why Galectin Therapeutics Inc Shares Are ... - Smarter Analyst"
p5
aS'Galectin Therapeutics to Present at 29th Annual ROTH Conference GlobeNewswire  - Mar 9, 2017 NORCROSS, Ga., March 09, 2017  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, today announced that Harold Shlevin, Ph.The Analysts Anticipate Galectin Therapeutics Inc  to Post ($0.17 ... - DailyQuint'
p6
aS'Galectin Therapeutics Inc  Given Average Rating of  by Brokerages The Cerbat Gem - 18 hours ago Galectin Therapeutics logo Galectin Therapeutics Inc  has been assigned an average broker rating score of 0.00  from the three brokers that cover the stock, Zacks Investment Research reports.Buy or Sell? What Analysts Recommends: Galectin Therapeutics, Inc. , SEI ... - StockNewsJournalThe Galectin Therapeutics Inc  Set to Announce Earnings on Tuesday - Petro Global News 24'
p7
aS'A Major Catalyst Awaits Galectin Therapeutics Next Week Seeking Alpha - Sep 23, 2016 Galectin Therapeutics  is a micro biotechnology company  focused on targeting galectin proteins.Two Speculative NASH Allocations Post Allergan plc Ordinary Shares (NYSE:AGN ... - Market Exclusive'
p8
aS'Galectin Therapeutics Announces $4 Million in New Equity Financings GlobeNewswire  - Dec 29, 2016 NORCROSS, Ga., Dec. 29, 2016  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, today announced it has recently completed a private placement of its common stock,&nbsp;...GALECTIN THERAPEUTICS INC.  Files An 8-K Entry into a Material ... - Market Exclusive'
p9
aS"Galectin Therapeutics and Aratana Therapeutics Look Forward to the 4th Quarter ... Yahoo Finance - Mar 15, 2017 A positive result from a small scale study on Galectin Therapeutics GR-MD-02 drug caused a 3.3 percent increase in the company's stock price, up 6 cents to $1.87 a share. The GR-MD-02 drug is designed to target the galectin-3 protein which plays a ..."
p10
a.